Diseases & Conditions News

vascular dementia

Causes and progression of vascular dementia

Helen Green, Dementia Specialist Nurse on Dementia UK’s Admiral Nurse Dementia Helpline, charts the causes and progression of vascular dementia.
infection control

Ensuring total infection control in 2021

Jackie Hook, Head Technical Chemist (CChem MRSC) at JLA Ltd underlines the importance of ensuring total infection control in 2021.
rare disease treatment

UK collaboration will revolutionise rare disease treatment

The Medicines Manufacturing Innovation Centre (MMIC) has developed a scalable, sustainable and more cost-effective way to manufacture oligonucleotides and treat rare diseases.
childhood trauma

Childhood trauma linked to multiple sclerosis development

Scientist have found that childhood trauma could affect the development and treatment of multiple sclerosis in adulthood.
insulin supplies

Diabetics are concerned about disrupted insulin supplies due to Brexit

Diabetics living in the UK are worried about disruption to insulin supplies as a result of Brexit, according to a new social media study.

Changing mealtimes could prevent type 2 diabetes

In a new study, researchers will examine if changing our mealtimes to earlier or later in the day could reduce the risk of developing Type 2 diabetes.
heart transplant

Adaptation after heart transplantation: A framework for the future

Anna Forsberg, Professor of Transplant Nursing at Lund University and Chair of the ETAHP Committee at the ESOT, explores a key area of development in heart transplant nursing as part of the build-up to ESOT Congress 2021.
UK Rare Diseases Framework

New framework to improve diagnosis and treatment of rare diseases

The new UK Rare Diseases Framework sets out to accelerate diagnosis and improve the treatment of rare diseases.
cardiac diagnosis, AF

A new era in cardiac diagnosis

Justin Hall, GM and VP EMEA, iRhythm Technologies, explores how modern technology is helping to diagnose Atrial Fibrillation (AF).
female athletes

The importance of supporting uniquely able bodied female athletes in uncertain times

Here, Mary Wilson, Paralympic athlete, shares her personal experience and health journey to highlight the importance of supporting disabled female athletes.
immunotherapy science

The beginning of the end for Type 1 diabetes: A new view from immunotherapy...

Jean Van Rampelbergh PhD, VP Clinical & Regulatory at Imcyse SA, introduces ImotopesTM a cutting-edge immunotherapy science with an excellent safety profile that could cure Type 1 diabetes or drastically change treatment options.
diarrheagenic e. coli

Transmission of Diarrheagenic E. coli by plants

Ann G. Matthysse, Professor of Biology from The University of North Carolina at Chapel Hill, shares her expertise on the transmission of Diarrheagenic E. coli by plants.
patient wellbeing

Diabetes: How can we improve patient wellbeing & national health outcomes?

Claus Møldrup, DrugsDisclosed.com Founder and Former Professor in Social Pharmacy at the University of Copenhagen, turns the spotlight on diabetes and explores how to improve patient wellbeing and national health outcomes.
Suppressing the spread of COVID-19

Suppressing the spread of COVID-19 in the Africa Region

Open Access Government was privileged to speak with Dr Mary Stephen again, Public Health Expert at the World Health Organization African Region, about suppressing the spread of COVID-19, remaining vigilant and effectively tackling any resurgence.
new HIV infections

Canada: Far behind other G7 countries in eliminating new HIV infections

Gary Lacasse, Executive Director with Kelly Puddister and Patrick Wright from the Canadian AIDS Society, argue that Canada is far behind other G7 countries in eliminating new HIV infections, with a 25.3% increase in new cases reported between 2014 and 2018.
Brain conditions

Brain conditions, mental and neurological alike

Prof Monica Di Luca, President, European Brain Council, sheds light on brain conditions, mental and neurological alike, starting with comment on the burdens presented.
effects of multiple sclerosis

A vision of a world free from the effects of multiple sclerosis

Dr Katie Howe, Research Communications Manager at the MS Society charts a vision of a world free from the effects of multiple sclerosis.
Dementia research in the UK

Dementia research in the UK and COVID-19

Samantha Benham-Hermetz, Director of Policy and Public Affairs at Alzheimer’s Research UK charts us through the priorities for dementia research in the UK in light of COVID-19.
improved body composition

How to fight diabetes with improved body composition

Here the InBody Clinical Team explain how improved body composition can help fight type 2 diabetes.
dementia tech

Dementia Tech: Overcoming barriers to innovation post-pandemic

Daniel Berman from Nesta Challenges and Colin Capper at the Alzheimer’s Society focus here on dementia tech, including comment on overcoming barriers to innovation post-pandemic.

Follow Open Access Government

Latest Special Reports

Latest Health eBooks